Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is the second most frequent type of primary liver cancer. ICC is among the deadliest malignancies, highlighting that novel treatments are urgently needed. Studies have shown that CD44 variant isoforms, rather than the CD44 standard isoform, are selectively expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bei, Yuncheng, He, Jian, Dong, Xuhui, Wang, Yuxin, Wang, Sijie, Guo, Wan, Cai, Chengjie, Xu, Zhiye, Wei, Jia, Liu, Baorui, Zhang, Nan, Shen, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Therapeutic Development and Chemical Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345965/
https://www.ncbi.nlm.nih.gov/pubmed/37205633
http://dx.doi.org/10.1158/0008-5472.CAN-23-0510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345965/
https://www.ncbi.nlm.nih.gov/pubmed/37205633
http://dx.doi.org/10.1158/0008-5472.CAN-23-0510

Ejemplares similares